CN103142676A - Bone setting blood stasis dispersing muscle tissue regeneration pill - Google Patents

Bone setting blood stasis dispersing muscle tissue regeneration pill Download PDF

Info

Publication number
CN103142676A
CN103142676A CN2012105239363A CN201210523936A CN103142676A CN 103142676 A CN103142676 A CN 103142676A CN 2012105239363 A CN2012105239363 A CN 2012105239363A CN 201210523936 A CN201210523936 A CN 201210523936A CN 103142676 A CN103142676 A CN 103142676A
Authority
CN
China
Prior art keywords
grams
blood stasis
muscle tissue
pill
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012105239363A
Other languages
Chinese (zh)
Inventor
杨本勤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012105239363A priority Critical patent/CN103142676A/en
Publication of CN103142676A publication Critical patent/CN103142676A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a bone setting blood stasis dispersing muscle tissue regenerating pill, and belongs to the technical field of medical preparations. The technical scheme includes that the bone setting blood stasis dispersing muscle tissue regenerating pill comprises 30-40 grams of madeira vine, 20-40 grams of asystasia chelonoides, 10-30 grams of gendarussa ventricosa, 10-20 grams of olibanum, 10-30 grams of myrrh and the balance adaptive processed honey. The bone setting blood stasis dispersing muscle tissue regenerating pill is composed of the madeira vine, the asystasia chelonoides, the gendarussa ventricosa, the olibanum, and the myrrh, and manufactured by the balance adaptive processed honey. The bone setting blood stasis dispersing muscle tissue regenerating pill is capable of tonifying and strengthening kidneys, dissipating blood stasis, eliminating a swelling, setting a bone, stopping bleeding, promoting blood circulation, relieving pain, dispersing the blood stasis, setting the bone, dispelling wind, eliminating dampness, eliminating the swelling, detoxifying, activating blood, promoting the circulation of qi, relieving pain of dysmenorrheal, eliminating the swelling and regenerating muscle tissue.

Description

A kind of synthetism blood stasis dispelling granulation promoting ball
Technical field: the invention belongs to the medicinal preparation technical field, is a kind of synthetism blood stasis dispelling granulation promoting ball specifically.
Background technology: human body has 206 bones, and the bone of each corresponding site is subject to all can fracturing after external force.At present, be mainly that after adopting manual reduction, plintlet is fixed, taken medicine and anti-inflammatory, repercussive and analgesic treatment or Traditional Chinese Medicine for external application blood circulation promoting and blood stasis dispelling clinically, can not promote that like this granulation promoting and sclerotin are involutory, treatment is long especially the course for the treatment of, and poisonous side effect of medicine is large, and therapeutic effect is not obvious.
Summary of the invention: the purpose of this invention is to provide a kind of synthetism blood stasis dispelling granulation promoting ball that curative effect is obvious when carrying out fractures to patient, toxic and side effects is little.
The present invention adopts following technical scheme.Every part by the ingredients that contains following active princlple scope:
Herba basellae rubrae potato rattan 30-40 gram; Asystasia gangetica (L) Anders.(A. Coromandelihas Nees) 20-40 gram; Ramulus Et Folium Adhatodae Ventricosea 10-30 gram; Olibanum 10-20 gram; Myrrha 10-30 gram; Surplus is adaptive with refined honey.
Every part of the present invention can be by the ingredients that contains following active component:
Herba basellae rubrae potato rattan 35 grams; Asystasia gangetica (L) Anders.(A. Coromandelihas Nees) 30 grams; Ramulus Et Folium Adhatodae Ventricosea 20 grams; Olibanum 15 grams; Myrrha 20 grams; Refined honey 120 grams.
The present invention is made of Herba basellae rubrae potato rattan, Asystasia gangetica (L) Anders.(A. Coromandelihas Nees), Ramulus Et Folium Adhatodae Ventricosea, Olibanum, Myrrha, and surplus is adaptive is made into pill with refined honey.Herba basellae rubrae potato rattan nature and flavor are bitter, temperature.Has replenishing kidney, strengthening waist, the effect of dissipating blood stasis for subsidence of swelling; The Asystasia gangetica (L) Anders.(A. Coromandelihas Nees) nature and flavor are hot, and are flat.Has dissipating blood stasis for subsidence of swelling, the effect of synthetism hemostasis; The Ramulus Et Folium Adhatodae Ventricosea nature and flavor are hot, hardship.Has promoting blood circulation and stopping pain, blood stasis dispelling synthetism, expelling wind and removing dampness, the effect of subduing swelling and detoxicating; The Olibanum nature and flavor are hot, hardship.Has blood-activating and qi-promoting, relieving pain of dysmenorrhea, the effect of detumescence and promoting granulation; The Myrrha nature and flavor are bitter, and are flat.Has promoting blood circulation and stopping pain, the effect of detumescence and promoting granulation.
Said components forms the comprehensive pharmacological action of medicine, can replenishing kidney, strengthening waist, dissipating blood stasis for subsidence of swelling, synthetism hemostasis, promoting blood circulation and stopping pain, blood stasis dispelling synthetism, expelling wind and removing dampness, subduing swelling and detoxicating, blood-activating and qi-promoting, relieving pain of dysmenorrhea, detumescence and promoting granulation, treatment to fracture has significant technique effect and advantage, up to 98%, has very high promotional value through the clinical observation cure rate.
The specific embodiment: a kind of synthetism blood stasis dispelling granulation promoting ball, every part by the ingredients that contains following active component:
Herba basellae rubrae potato rattan 35 grams; Asystasia gangetica (L) Anders.(A. Coromandelihas Nees) 30 grams; Ramulus Et Folium Adhatodae Ventricosea 20 grams; Olibanum 15 grams; Myrrha 20 grams.To add pellet processing machine to be made into packing after pill after after the dry porphyrize of said medicine, sterilization adds refined honey 120 grams to stir again, each serving using 2 grams, get final product every day for three times.

Claims (1)

1. synthetism blood stasis dispelling granulation promoting ball, Herba basellae rubrae potato rattan 35 grams; Asystasia gangetica (L) Anders.(A. Coromandelihas Nees) 30 grams; Ramulus Et Folium Adhatodae Ventricosea 20 grams; Olibanum 15 grams; Myrrha 20 grams add pellet processing machine to be made into pill after after the dry porphyrize of said medicine, sterilization adds refined honey 120 grams to stir again.
CN2012105239363A 2012-11-28 2012-11-28 Bone setting blood stasis dispersing muscle tissue regeneration pill Pending CN103142676A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012105239363A CN103142676A (en) 2012-11-28 2012-11-28 Bone setting blood stasis dispersing muscle tissue regeneration pill

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012105239363A CN103142676A (en) 2012-11-28 2012-11-28 Bone setting blood stasis dispersing muscle tissue regeneration pill

Publications (1)

Publication Number Publication Date
CN103142676A true CN103142676A (en) 2013-06-12

Family

ID=48541185

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012105239363A Pending CN103142676A (en) 2012-11-28 2012-11-28 Bone setting blood stasis dispersing muscle tissue regeneration pill

Country Status (1)

Country Link
CN (1) CN103142676A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105168380A (en) * 2015-08-27 2015-12-23 廖国荣 Dai medicine bone setting powder and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102657824A (en) * 2012-05-22 2012-09-12 戴伟 Medicine used for treating fracture

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102657824A (en) * 2012-05-22 2012-09-12 戴伟 Medicine used for treating fracture

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
孙绍良: "活血化淤法在骨折上的应用", 《福建中医药》, vol. 19, no. 1, 31 December 1988 (1988-12-31), pages 40 *
朱成兰;等: "傣药大驳骨丹的生药学研究", 《云南中医中药杂志》, vol. 25, no. 4, 31 December 2004 (2004-12-31), pages 36 - 37 *
李保真;等: "广西壮族民间药用植物的初步研究(五)", 《广西医学》, vol. 7, no. 4, 31 December 1985 (1985-12-31), pages 187 - 191 *
李纯丽;等: "保健蔬菜——藤三七", 《特种经济动植物》, no. 6, 31 December 2006 (2006-12-31), pages 28 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105168380A (en) * 2015-08-27 2015-12-23 廖国荣 Dai medicine bone setting powder and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN103705613A (en) External-use drug for treating burns and scalds
CN100434109C (en) Medicine ointment for treating burns and scalds and its prepn
CN101757333A (en) External traditional Chinese medicament preparation for treating arthralgia
CN103393895B (en) Bone-setting traditional Chinese medicine decoction and preparation method thereof
CN101919927B (en) Spray for promoting scald healing
CN102552361A (en) Externally applied medicinal liquor and preparation method thereof
CN103768388A (en) Traditional Chinese medicine formula for treating scalds, burns and trauma by being singly applied externally
CN102727698B (en) Wound surface nursing powder for treating bedsore
CN104474528A (en) Medicine used for drainage detoxification
CN101543555B (en) Combined medicine for treating burn and scald
CN103142676A (en) Bone setting blood stasis dispersing muscle tissue regeneration pill
CN103585257B (en) A kind of Chinese powder medicine for the treatment of fracture
CN101780193A (en) Special-effect plaster for treating fractures and various non-healing wounds
CN105663370A (en) Externally-used medicine for treating verruca plantaris
CN106266361A (en) A kind of External-applicationChinese Chinese medicinal preparation treating cervical and lumbar diseases
CN102657824A (en) Medicine used for treating fracture
CN101254245A (en) Fast-healing Chinese herbal medicine burns and scald agent
CN104547591A (en) Pharmaceutical composition for treating acute ankle sprain
CN105641282B (en) External traditional Chinese medicine composition for treating neck, shoulder, waist and leg pain
CN101244138B (en) Externally used traditional Chinese medicine preparation for treating frostbite
CN103070935A (en) Drug for curing acne
CN103239536B (en) Traditional Chinese medicine for treating influenza and preparation method thereof
CN102000219B (en) Medicament for treating burns and scalds as well as preparation and use method thereof
CN105521163A (en) Medicine for treating scabies in cattle
CN105326972A (en) External medicine composition for treating traumata and skin and external diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130612